Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidationShao‐Wen Weng, Pei‐Wen Wang, Jian‐Ching Wu et al.|Diabetologia|2023Cited by 42
Clinical care guidance in patients with diabetes and metabolic dysfunction–associated steatotic liver disease: A joint consensusJee‐Fu Huang, Ming‐Lung Yu, Chi‐Ming Tai et al.|Hepatology Communications|2024Cited by 15